CalciMedica (CALC) Gains from Investment Securities (2022 - 2026)

CalciMedica (CALC) has 5 years of Gains from Investment Securities data on file, last reported at -$7.8 million in Q1 2026.

• Quarterly Gains from Investment Securities fell 466.45% year-over-year to -$7.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.4 million (up 11.22% YoY) and the FY2025 annual result came in at $5.2 million, up 155.04% from the prior year.
• Gains from Investment Securities declined to -$7.8 million in Q1 2026, from $5.4 million in the prior quarter.
• In the past five years, Gains from Investment Securities ranged from a high of $5.4 million in Q4 2025 to a low of -$7.8 million in Q1 2026.
• A 5-year average of -$834357.1 and a median of -$584500.0 in 2022 frame the typical range for Gains from Investment Securities.
• Annual changes were most pronounced in 2025 — Gains from Investment Securities surged 417.65% — and 2026, when it tumbled 466.45%.
• Tracing CALC's Gains from Investment Securities over 5 years: stood at -$1.7 million in 2022, then surged by 32.86% to -$1.1 million in 2023, then tumbled by 48.34% to -$1.7 million in 2024, then surged by 417.65% to $5.4 million in 2025, then plunged by 244.44% to -$7.8 million in 2026.
• The last three Gains from Investment Securities figures came in at -$7.8 million (Q1 2026), $5.4 million (Q4 2025), and $800000.0 (Q3 2025), per Business Quant data.